CTOs on the Move

Sotera Wireless

www.soterawireless.com

 
Sotera Wireless is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Diego, CA. To find more information about Sotera Wireless, please visit www.soterawireless.com
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

AOSpine North America

AOSpine North America is a Paoli, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hollenbeck Home

Serving the Greater Los Angeles area for more than a century, men and women in their senior years have enjoyed Hollenbeck`s vibrant, rewarding and comfortable environment, where friendships grow as personal interests are pursued. Hollenbeck Palms offers independent residential living, assisted residential living and skilled nursing services. Please refer to the main menu to view each of these opportunities for aging-in-place. Give us a call to schedule a convenient time to visit and enjoy an escorted tour of our impressive facilities and a complimentary lunch in our Grand Dining Room.

Npl Home Care Inc

Npl Home Care Inc is a Elyria, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JustRight Surgical, LLC

JustRight Surgical was founded in order to address a previously unmet need: the ability for pediatric surgeons to safely and effectively perform minimally invasive surgery in pediatric patients from neonate to teenager. Up until 2010, the only devices available for use in pediatric surgery were high-powered adult-sized instruments, which cause access issues and visualization problems during procedures.

Scynexis

SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.